Coversin, a novel complement C5 inhibitor and potential therapeutic agent, prevents C5 activation in patients with C5 polymorphisms: OR154
- Resource Type
- Academic Journal
- Source
- Journal of Thrombosis and Haemostasis. Jun 01, 2015 13 Suppl 2:153-154
- Subject
- Language
- English
- ISSN
- 1538-7933